# Carecubes

> Carecubes makes the Carecube, an FDA 510(k)-cleared negative-pressure isolation canopy that turns any standard hospital bed into an airborne-isolation unit in about 20 minutes. Born from a DARPA-funded Ebola-era project at San Francisco research lab Otherlab, the device pulls air through an H14 HEPA filter, holds negative pressure, and lets caregivers reach patients through glove walls - isolating the pathogen instead of the patient. The Arden Hills, Minnesota company closed a $6.5M Series A in March 2026 and has deployed across dozens of communities and health systems.

- **Founded:** 2020
- **Headquarters:** Arden Hills, Minnesota, United States
- **Founders:** Alex Laskey (Founder & Executive Chairman (former CEO)), Saul Griffith (Co-founder (founder of Otherlab, MacArthur Fellow))
- **Team size:** ~14 employees
- **Products:** The Carecube (Negative Pressure Isolation Chamber), Carecube ISTARI
- **Notable:** Received FDA 510(k) clearance for the Carecube isolation unit, Closed a $6.5 million Series A in March 2026 backed by prominent healthcare executives, Deployed across 47 communities in 15 states and territories

## Products & services

- **The Carecube (Negative Pressure Isolation Chamber)** — An FDA 510(k)-cleared canopy that surrounds a standard hospital bed to create a negative-pressure airborne-isolation space. H14 HEPA filtration removes 99.997% of particulates at 0.3 microns, delivers 15+ air exchanges per hour, and holds negative pressure at or below -2.5 pascals to meet CDC guidance for airborne infection isolation rooms. Sets up in about 20 minutes with lean-in glove walls, conduit panels for equipment, and pass-through panels for meals and waste.
- **Carecube ISTARI** — The market model of the Carecube isolation unit built for rapid deployment across hospitals, public health agencies, and emergency response settings.

## Achievements

- Received FDA 510(k) clearance for the Carecube isolation unit
- Closed a $6.5 million Series A in March 2026 backed by prominent healthcare executives
- Deployed across 47 communities in 15 states and territories
- Meets CDC guidance for airborne infection isolation rooms and Joint Commission Standard IC.07.01.01
- Subject of clinical trials evaluating patient comfort and environmental conditions
- Manufactured in the USA with a domestic supply chain

## Latest updates

- **2026-06** — Named healthcare technology executive Kabir Gulati as CEO; founder Alex Laskey transitioned to Executive Chairman as the company accelerates national expansion.
- **2026-03** — Closed a $6.5 million Series A to scale manufacturing and infectious-disease response deployment.

## Links

- Website: https://carecubes.com
- LinkedIn: https://www.linkedin.com/company/carecubes

---

Profile page: https://yespress.io/carecubes
Published by YesPress — https://yespress.io
Last updated: 2026-07-13